GlobeNewswire
Fulcrum Therapeutics to Host Investor Event to Review New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease on December 7, 2025
📊
AI Sentiment
Positive
7/10
Fulcrum Therapeutics Inc. News
Latest updates and market news for FULC
1 news
Dec 2 - Dec 8, 2025
Page 1
Share this news page